Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Change in Accured Expenses (2023 - 2025)

Rallybio's Change in Accured Expenses history spans 3 years, with the latest figure at -$350000.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses rose 89.33% year-over-year to -$350000.0; the TTM value through Sep 2025 reached -$2.6 million, up 2.39%, while the annual FY2024 figure was -$3.3 million, 131.74% down from the prior year.
  • Change in Accured Expenses for Q3 2025 was -$350000.0 at Rallybio, down from $1.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.6 million in Q2 2025 and bottomed at -$3.6 million in Q1 2023.
  • The 3-year median for Change in Accured Expenses is -$350000.0 (2025), against an average of -$542636.4.
  • The largest annual shift saw Change in Accured Expenses tumbled 316.01% in 2024 before it surged 2796.43% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at -$687000.0 in 2023, then plummeted by 102.77% to -$1.4 million in 2024, then soared by 74.87% to -$350000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Change in Accured Expenses are -$350000.0 (Q3 2025), $1.6 million (Q2 2025), and -$2.5 million (Q1 2025).